Kamada (KMDA) Quick Ratio: History & Chart

Kamada Ltd.(KMDA)

Drug Manufacturers - Specialty & Generic · Rehovot, HM

$8.01+0.01 (+0.12%)

Delayed quote: Oct 6, 2026, 11:30 AM EDT

About Kamada Ltd.

Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its proprietary product segment and its distribution division. Its own manufactured portfolio includes KAMRAB/KEDRAB for rabies prevention, CYTOGAM to prevent cytomegalovirus disease in transplant recipients, WINRHO SDF for immune thrombocytopenic purpura and Rhesus (Rh) isoimmunization, HEPAGAM B for hepatitis B recurrence prevention following liver transplants and for post-exposure prophylaxis, VARIZIG for post-exposure chickenpox prophylaxis, and GLASSIA for intravenous alpha-1 antitrypsin deficiency (AATD). Kamada also produces KamRho (D) for the prophylaxis of hemolytic disease of newborns and immune thrombocytopenic purpura, along with a specific antiserum for Vipera palaestinae and Echis coloratus snake bites. Additionally, the company distributes a wide array of third-party pharmaceutical products, encompassing treatments like BRAMITOB for chronic pulmonary infections, FOSTER for asthma, PROVOCHOLINE for diagnosing bronchial airway hyperactivity, and specialized therapies such as IVIG for immunodeficiency, VARITECT for chickenpox and zoster herpes, and various factors for hemophilia A and B, among numerous others for conditions like hepatitis B, cytomegalovirus, angioedema, Japanese encephalitis, and prostate cancer. Kamada markets its offerings in the United States through strategic partners and internationally via a network of distributors. The company maintains significant collaborations with Takeda Pharmaceuticals Company Limited, PARI GmbH, and Kedrion Biopharma. Established in 1990, Kamada Ltd. is headquartered in Rehovot, Israel.

Rehovot, HM

462 employees

www.kamada.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Amir London

View full financials

KMDA Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

2.29

QUICK RATIO (ACID-TEST) AVG TTM

2.19

QUICK RATIO (ACID-TEST) AVG 3Y

2.08

QUICK RATIO (ACID-TEST) AVG 5Y

1.70

QUICK RATIO (ACID-TEST) AVG 10Y

2.54

QUICK RATIO (ACID-TEST) AVG 15Y

2.29

QUICK RATIO (ACID-TEST) AVG 20Y

N/A

CURRENT VS TTM AVG

+4.86%

CURRENT VS 3Y AVG

+10.16%

CURRENT VS 5Y AVG

+34.94%

CURRENT VS 10Y AVG

-9.90%

CURRENT VS 15Y AVG

-0.02%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

3.11

median of 684 covered companies

CURRENT VS SECTOR MEDIAN

-26.28%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
Kamada Ltd. (KMDA)	$462.13M	2.29	2.19	2.08	1.70
NRC Health (NRC)vs ›	$464.03M	0.65	0.55	0.77	1.10
DiaMedica Therapeutics Inc. (DMAC)vs ›	$454.18M	6.72	10.04	13.74	16.43
Ovid Therapeutics Inc. (OVID)vs ›	$452.60M	12.39	8.12	11.14	10.14
Cerus Corporation (CERS)vs ›	$475.60M	1.07	1.48	1.43	1.74
Capricor Therapeutics, Inc. (CAPR)vs ›	$449.16M	7.35	8.39	5.06	6.73
Contineum Therapeutics, Inc. (CTNM)vs ›	$476.50M	37.17	24.09	19.47	19.38
Bright Minds Biosciences Inc. (DRUG)vs ›	$478.35M	121.97	23.71	19.95	19.50
Assembly Biosciences, Inc. (ASMB)vs ›	$444.90M	13.99	3.82	4.27	5.98
Arvinas, Inc. (ARVN)vs ›	$482.62M	7.91	4.78	4.69	6.49

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

Kamada Ltd. (KMDA)

$462.13M

2.29

2.19

2.08

1.70

NRC Health (NRC)vs ›

$464.03M

0.65

0.55

0.77

1.10

DiaMedica Therapeutics Inc. (DMAC)vs ›

$454.18M

6.72

10.04

13.74

16.43

Ovid Therapeutics Inc. (OVID)vs ›

$452.60M

12.39

8.12

11.14

10.14

Cerus Corporation (CERS)vs ›

$475.60M

1.07

1.48

1.43

1.74

Capricor Therapeutics, Inc. (CAPR)vs ›

$449.16M

7.35

8.39

5.06

6.73

Contineum Therapeutics, Inc. (CTNM)vs ›

$476.50M

37.17

24.09

19.47

19.38

Bright Minds Biosciences Inc. (DRUG)vs ›

$478.35M

121.97

23.71

19.95

19.50

Assembly Biosciences, Inc. (ASMB)vs ›

$444.90M

13.99

3.82

4.27

5.98

Arvinas, Inc. (ARVN)vs ›

$482.62M

7.91

4.78

4.69

6.49

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Kamada Ltd. (KMDA)?

The quick ratio (acid-test) for KMDA stock is 2.29.

Is Kamada Ltd.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 2.29 is 35% above its 5-year average of 1.70, around the middle of its 5-year range (0.75–5.15).

What is the TTM average quick ratio (acid-test) for Kamada Ltd. (KMDA)?

The TTM average quick ratio (acid-test) for KMDA stock is 2.19.

What is the 3Y average quick ratio (acid-test) for Kamada Ltd. (KMDA)?

The 3Y average quick ratio (acid-test) for KMDA stock is 2.08.

What is the 5Y average quick ratio (acid-test) for Kamada Ltd. (KMDA)?

The 5Y average quick ratio (acid-test) for KMDA stock is 1.70.

What is the 10Y average quick ratio (acid-test) for Kamada Ltd. (KMDA)?

The 10Y average quick ratio (acid-test) for KMDA stock is 2.54.

What is the 15Y average quick ratio (acid-test) for Kamada Ltd. (KMDA)?

The 15Y average quick ratio (acid-test) for KMDA stock is 2.29.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	2.29
2026-03-31	1.90
2025-12-31	2.28
2025-09-30	2.24
2025-06-30	2.21
2025-03-31	1.93
2024-12-31	2.14
2024-09-30	2.73
2024-06-30	2.14
2024-03-31	1.98
2023-12-31	1.64
2023-09-30	2.13
2023-06-30	0.75
2023-03-31	0.75
2022-12-31	0.88
2022-09-30	0.90
2022-06-30	1.09
2022-03-31	1.22
2021-12-31	1.08
2021-09-30	4.92
2021-06-30	5.15
2021-03-31	6.09
2020-12-31	5.40
2020-09-30	5.69
2020-06-30	4.21
2020-03-31	4.91
2019-12-31	3.07
2019-09-30	4.49
2019-06-30	3.40
2019-03-31	3.82
2018-12-31	3.46
2018-09-30	3.31
2018-06-30	2.85
2018-03-31	2.44
2017-12-31	2.58
2017-09-30	2.73
2017-06-30	1.95
2017-03-31	1.71
2016-12-31	1.89
2016-09-30	2.41
2016-06-30	2.24
2016-03-31	1.95
2015-12-31	2.37
2015-09-30	1.99
2015-06-30	2.30
2015-03-31	2.27
2014-12-31	2.34
2014-09-30	2.50
2014-06-30	2.47
2014-03-31	2.57
2013-12-31	2.94
2013-09-30	3.59
2013-06-30	3.35
2013-03-31	1.45
2012-12-31	1.68
2012-09-30	2.01
2012-06-30	0.00

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

2.29

2026-03-31

1.90

2025-12-31

2.28

2025-09-30

2.24

2025-06-30

2.21

2025-03-31

1.93

2024-12-31

2.14

2024-09-30

2.73

2024-06-30

2.14

2024-03-31

1.98

2023-12-31

1.64

2023-09-30

2.13

2023-06-30

0.75

2023-03-31

0.75

2022-12-31

0.88

2022-09-30

0.90

2022-06-30

1.09

2022-03-31

1.22

2021-12-31

1.08

2021-09-30

4.92

2021-06-30

5.15

2021-03-31

6.09

2020-12-31

5.40

2020-09-30

5.69

2020-06-30

4.21

2020-03-31

4.91

2019-12-31

3.07

2019-09-30

4.49

2019-06-30

3.40

2019-03-31

3.82

2018-12-31

3.46

2018-09-30

3.31

2018-06-30

2.85

2018-03-31

2.44

2017-12-31

2.58

2017-09-30

2.73

2017-06-30

1.95

2017-03-31

1.71

2016-12-31

1.89

2016-09-30

2.41

2016-06-30

2.24

2016-03-31

1.95

2015-12-31

2.37

2015-09-30

1.99

2015-06-30

2.30

2015-03-31

2.27

2014-12-31

2.34

2014-09-30

2.50

2014-06-30

2.47

2014-03-31

2.57

2013-12-31

2.94

2013-09-30

3.59

2013-06-30

3.35

2013-03-31

1.45

2012-12-31

1.68

2012-09-30

2.01

2012-06-30

0.00

Quick Ratio (Acid-Test): 2.29

KMDA Quick Ratio

KMDA Average Quick Ratio (Acid-Test) Chart

KMDA Current vs Average Quick Ratio (Acid-Test) Chart

KMDA Quick Ratio (Acid-Test) Metrics

KMDA Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

KMDA Quick Ratio (Acid-Test) History

Related Metrics